Atrial natriuretic factor messenger ribonucleic acid and peptide in the human heart during ontogenic development.
We have investigated the level of expression of the atrial natriuretic factor (ANF) gene in the human heart during ontogenic development by determining the concentrations of ANF messenger ribonucleic acid (ANF mRNA), of immunoreactive ANF (IR ANF) and of receptor reactive ANF (RR ANF), in myocardial samples of the various heart chambers. We found the level was high and almost identical in the left and right ventricles in utero. It gradually decreased during ontogenic development to reach the low adult levels, with a more rapid decrease in the right than in the left ventricle after birth. In the atria, ANF gene expression was high as early as the 13th week of gestation, was higher in the right than in the left atrium, and appeared little affected by ontogenic development.
Mercadier
J J
JJ
INSERM U 127, Hôpital Lariboisière, Paris, France.
Zongazo
M A
MA
Wisnewsky
C
C
Butler-Brown
G
G
Gros
D
D
Carayon
A
A
Schwartz
K
K
D000375:Aging; D009320:Atrial Natriuretic Factor / Q000032:analysis* / Q000502:physiology; D015152:Blotting, Northern; D002648:Child; D005314:Embryonic and Fetal Development; D006801:Humans; D008875:Middle Aged; D009206:Myocardium / Q000032:analysis*; D010455:Peptides / Q000032:analysis* / Q000502:physiology; D012333:RNA, Messenger / Q000032:analysis* / Q000502:physiology; D011863:Radioimmunoassay; D011869:Radioligand Assay
C472955:NPPA protein, human; D010455:Peptides; D012333:RNA, Messenger; D009320:Atrial Natriuretic Factor